A Noninvasive Clinical Scoring Model Predicts Risk of Nonalcoholic Steatohepatitis in Morbidly Obese Patients

[1]  P. Bejarano.  Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD—Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network , 2010 .

[2]  Z. Goodman,et al.  T1011 Independent Predictors of Fibrosis in a Large Cohort of Patients with Non-Alcoholic Fatty Liver Disease , 2009 .

[3]  B. Neuschwander‐Tetri,et al.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network , 2009, Hepatology.

[4]  S. Tsang,et al.  Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels , 2009, Alimentary pharmacology & therapeutics.

[5]  J. Layden-Almer,et al.  The Histologic Spectrum of Liver Disease in African-American, Non-Hispanic White, and Hispanic Obesity Surgery Patients , 2009, The American Journal of Gastroenterology.

[6]  K. Sung,et al.  severity of nonalcoholic fatty liver disease is associated with ncreased cardiovascular risk in a large cohort of non-obese sian subjects i , 2009 .

[7]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[8]  L. N. Valenti,et al.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.

[9]  E. Vittinghoff,et al.  A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients , 2008, Hepatology.

[10]  F. Yao.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes , 2008 .

[11]  J. Machan,et al.  Nonalcoholic Fatty Liver Disease in Severely Obese Subjects , 2007, The American Journal of Gastroenterology.

[12]  Jeanne M Clark,et al.  The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults , 2006, Journal of clinical gastroenterology.

[13]  S. Msika,et al.  Prevalence and Predictive Factors of Non-Alcoholic Steatohepatitis (NASH) in Morbidly Obese Patients Undergoing Bariatric Surgery , 2006, Obesity surgery.

[14]  N. Patel,et al.  Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. , 2006, Annals of hepatology.

[15]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[16]  Z. Goodman,et al.  Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients , 2005, Obesity surgery.

[17]  M. Charlton.  Nonalcoholic fatty liver disease: a review of current understanding and future impact. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  G. Tarantino,et al.  Silent non-alcoholic fatty liver disease-a clinical-histological study. , 2004, Journal of hepatology.

[19]  A. Lazenby,et al.  Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease , 2004, Hepatology.

[20]  Z. Younossi,et al.  Nonalcoholic fatty liver disease in patients with type 2 diabetes. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  E. Björnsson,et al.  High prevalence of metabolic complications in patients with non‐alcoholic fatty liver disease , 2004, Scandinavian journal of gastroenterology.

[22]  T. Trainer,et al.  Prevalence of Non-alcoholic Steatohepatitis in Morbidly Obese Subjects Undergoing Gastric Bypass , 2003, Obesity surgery.

[23]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[24]  Sang-hun Park.  Expanding the Natural History of Nonalcoholic Steatohepatitis: from Cryptogenic Cirrhosis to Hepatocellular Carcinoma , 2003 .

[25]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[26]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[27]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[28]  K. Lindor,et al.  The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease , 1999, American Journal of Gastroenterology.

[29]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.